Treatment of standard- and high-risk childhood acute lymphoblastic leukaemia with two CNS prophylaxis regimens.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D008577:Meningeal Neoplasms / Q000517:prevention & control*; D008727:Methotrexate / Q000008:administration & dosage; D011882:Radiotherapy, High-Energy; D012074:Remission Induction; D012306:Risk; D013997:Time Factors
D003561:Cytarabine; D008727:Methotrexate